More Business Wire
View Older Stories View Newer Stories-
The SBB Research Group Foundation Sponsors The Center for Enriched Living
-
ICE Brent and ICE WTI Perpetual Futures to Launch on OKX
-
Fifth Third Bancorp Announces Results of Early Participation in Private Exchange Offers and Consent Solicitations
-
Schrödinger Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4)
-
Hyperfine Announces Presentation of Results from the PRIME Study Showing Portable MRI Substantially Reduces Time to Imaging in Emergency Departments
-
Witness to War Foundation Observes Memorial Day and Celebrates 25 Years of Preserving Oral Histories of Combat Veterans
-
ClearNote Health to Present Early Detection Validation Data for Avantect® Pancreatic Cancer Test at 2026 ASCO Annual Meeting
-
XiFin Applauds House Ways and Means Committee Advancement of the Main Street Pharmacy Access Act
-
Agilent Unveils the 9500 ICP-MS: Redefining Trace Element Analysis
-
Henry Schein Announces the Election of William K. “Dan” Daniel as Independent Chairman of the Board
-
AI & Tech Sandbox Unveils Cannes Lions 2026 Programming Focused on Learning, Discovery, and What’s Next in AI
-
Enhertu® Recommended for Approval in the EU by CHMP for Patients with Previously Treated HER2 Positive Metastatic Solid Tumors
-
BBRC Corrects the Record on Victoria’s Secret’s Investor Presentation
-
Rivian to Participate at Upcoming Investor Conferences
-
Hamilton ETFs Announces May 2026 Monthly & Upcoming Semi-Monthly Cash Distributions
-
Nakamoto Announces Expansion of Board of Directors
-
NTT, NTT DATA and INDYCAR Extend Entitlement Partnership with Multi-Year Agreement
-
Veracyte to Host Investor Call on June 1, 2026 to Discuss ASCO Findings
-
Operation HOPE’s First Quarter 2026 HOPE Insider Survey Reveals Economic Anxiety Persists, but Financial Literacy Support is Building Resilience
-
Slate Grocery REIT Special Committee to Review Strategic Alternatives
-
Walmart Leadership to Participate in Upcoming Investor Events
-
Merck Receives Positive EU CHMP Opinion for KEYTRUDA® (pembrolizumab) Plus Padcev® (enfortumab vedotin-ejfv) as Perioperative Treatment for Adults With Cisplatin-Ineligible Resectable Muscle-Invasiv
-
Contract Professionals, Inc. Founder Steve York Announces Retirement After 44 Years
-
Gilead Receives CHMP Positive Opinion for Trodelvy® in First-Line Metastatic Triple-Negative Breast Cancer for Patients Not Candidates for PD-(L)1 Inhibitors
-
Future Health Challenge Awards USD 300,000 to Early Detection and Population Health Sensing Tools on Sidelines of World Health Assembly
-
ImmunityBio Highlights Patient Survey Data at ISPOR 2026 Showing Majority of UK Adults Living with NMIBC Favor Bladder Preservation
-
ImmunityBio Presents Health Economic Analysis at ISPOR 2026 Showing ANKTIVA® Plus BCG Delivers Lower Cost per Sustained Complete Response Versus TAR-200 in BCG-Unresponsive NMIBC CIS
-
Boys & Girls Clubs of America Expands Trauma-Informed Approach to Advance Youth Mental Wellness Nationwide
-
Sherritt Announces Failure-To-File Cease Trade Order
-
AstraZeneca to showcase Phase III data in liver, breast and bladder cancers and potential first-in-class rare disease therapy at ASCO 2026
-
Solmate Infrastructure (Nasdaq: SLMT) Highlights CEO and Board Member Investment
-
Michael Carrick Continues as Head Coach
-
BJ’s Wholesale Club Receives First-Time Investment Grade Rating from Fitch
-
SAGA Diagnostics to Present Data on Ultrasensitive Pathlight™ MRD Test in Breast, Colon, and Rectal Cancers at ASCO 2026
-
Granite REIT Announces Renewal of Normal Course Issuer Bid
-
Foundation Medicine Showcases Innovation at 2026 ASCO® Annual Meeting
-
BJ’s Wholesale Club Holdings, Inc. Announces First Quarter Fiscal 2026 Results
-
Ferguson Enterprises Inc. (“Company”): Execution of Rule 10b5-1 Plans
-
Booz Allen Hamilton Announces Fourth Quarter and Full Year Fiscal 2026 Results
-
The NYSE Accepts Natuzzi’s Plan to Regain Compliance with Continued Listing Standards
-
Starfighters Space (NYSE American: FJET) Advances STARLAUNCH Program and Commercial Space Development Through Strategic $17.5 Million Investment
-
First lululemon Stores in Greece to Open in Athens
-
Tikehau Capital: Disclosure of Shares Repurchases From 15 May 2026 to 21 May 2026
-
TotalEnergies SE: Capital increase reserved for employees of TotalEnergies in 2026
-
Pivotal Trial Data for EP0031 (A400), a Next-Generation Selective RET Inhibitor (SRI), in RET Positive Advanced NSCLC, to be Presented at ASCO 2026
-
Karooooo to Present at William Blair Growth Stock Conference
-
FPT Launches Flezi Foundry™, Advancing AI-Augmented Delivery for Global Enterprises
-
KBRA Releases Research – European Data Centre Event—KBRA Event Recap
-
E3 Lithium Releases Q1 2026 Results and Continues Advancement Toward Commercialization
-
CoStar Data Shows Office Yield Gap Narrowing Between London and the Big Six

